Inhibition of hepatitis E virus replication by proteasome inhibitor is nonspecific.

about

Therapeutic targets for the treatment of hepatitis E virus infection Recent Advances Towards the Development of a Potent Antiviral Against the Hepatitis E Virus

P2860

Q28084036-1B0FCBBE-4D6D-48A6-9742-B4E99546BF0C Q57066905-F34661E7-AD03-48BC-8CBF-0F4ED3EDDB2A

P2860

Inhibition of hepatitis E virus replication by proteasome inhibitor is nonspecific.

Item

http://www.wikidata.org/entity/Q38932122

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Inhibition of hepatitis E virus replication by proteasome inhibitor is nonspecific.

@en

type

Item

label

Inhibition of hepatitis E virus replication by proteasome inhibitor is nonspecific.

@en

prefLabel

Inhibition of hepatitis E virus replication by proteasome inhibitor is nonspecific.

@en

P1476

Inhibition of hepatitis E virus replication by proteasome inhibitor is nonspecific.

@en

P2093

Lei Xu

http://www.w3.org/2001/XMLSchema#string

Xinying Zhou

http://www.w3.org/2001/XMLSchema#string

P2860

E6AP ubiquitin ligase mediates ubiquitylation and degradation of hepatitis C virus core protein

Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules

SARS-CoV nucleocapsid protein binds to hUbc9, a ubiquitin conjugating enzyme of the sumoylation system.

Epidemiology and management of chronic hepatitis E infection in solid organ transplantation: a comprehensive literature review.

The leader proteinase of foot-and-mouth disease virus negatively regulates the type I interferon pathway by acting as a viral deubiquitinase.

Proteasome inhibition: a new anti-inflammatory strategy.

The proteasome: a suitable antineoplastic target.

Hepatitis E virus replication requires an active ubiquitin-proteasome system.

Translational control by viral proteinases.

The ubiquitin-proteasome pathway in viral infections.

P2888

s00705-014-2303-0

P304

435-439

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1007/S00705-014-2303-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

160

http://www.w3.org/2001/XMLSchema#string

P50

Qiuwei Pan

Maikel P Peppelenbosch

P577

2014-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269181193

http://www.w3.org/2001/XMLSchema#string

P6179

1020128647

http://www.w3.org/2001/XMLSchema#string

P698

25476751

http://www.w3.org/2001/XMLSchema#string

P932

7087333

http://www.w3.org/2001/XMLSchema#string

Inhibition of hepatitis E virus replication by proteasome inhibitor is nonspecific.

about

P2860

P2860

Inhibition of hepatitis E virus replication by proteasome inhibitor is nonspecific.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698

P932